---
title: Discovery Research CROs in Asia-Pacific
path: /services/discovery-research/apac
companies_count: 15
---

# Discovery Research CROs in Asia-Pacific

15 published CROs match Discovery Research in Asia-Pacific.

Locations in this set include United States, China, India, United Kingdom, Australia, and Italy.

Capabilities that show up most often in this set: Small Molecule, Antibody-Drug Conjugate (ADC), Biologics (Monoclonal Antibodies), Biologics (Other), and Oligonucleotide.

## Matching companies

- [Aragen Life Sciences](/companies/aragen)
  - Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.
- [Aurigene Pharmaceutical Services Limited](/companies/aurigeneservices)
  - Integrated CRO-CDMO with 25+ years of discovery and development expertise across small and large molecules, operating 16 US FDA-inspected cGMP facilities across three manufacturing countries.
- [ChemDiv](/companies/chemdiv)
  - ChemDiv is a fully integrated target-to-clinic CRO headquartered in San Diego, CA, offering drug discovery services including medicinal chemistry, CADD, ADME/DMPK, toxicology, and custom synthesis alongside the industry's largest commercial screening library of 1.6M compounds.
- [ChemPartner](/companies/chempartner)
  - Global preclinical CRO with 20+ years of experience supporting drug discovery through IND submission across small molecules and biologics, with 2,000+ scientists and facilities worldwide.
- [Crown Bioscience](/companies/crownbio)
  - Preclinical oncology CRO offering 2,500+ PDX models, organoid and cell line databases, and translational platforms with biomarker discovery and AI-driven systems biology for drug development.
- [HitGen Inc.](/companies/hitgen)
  - HitGen Inc. provides drug discovery services built on DNA-encoded library (DEL), fragment-based (FBDD/SBDD) and computational platforms for pharmaceutical and biotech clients. The company also offers oligonucleotide CDMO services and reports serving more than 600 clients globally.
- [IPM Biotech](/companies/ipmbiotech)
  - IPM Biotech (生创精准医疗科技有限公司) is a cell technology and regenerative medicine company founded in 2015 by a team of renowned returnee scientists specializing in stem cells and regenerative medicine.
- [KCAS Bio](/companies/kcasbio)
  - Leading bioanalytical CRO with 45+ years of experience, supporting 315+ approved drugs through bioanalysis, biomarker, immunogenicity, flow cytometry, and clinical kitting services across US, EU, and Australia facilities.
- [PI Health Sciences](/companies/pihealthsciences)
  - PI Health Sciences is an integrated CRDMO offering end-to-end drug discovery, development, and manufacturing services with R&D and manufacturing locations in Europe and India.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [Sapala Organics](/companies/sapalaorganics)
  - Custom synthesis of nucleic acid building blocks, modified phosphoramidites and oligonucleotide delivery compounds, plus FTE-based CRO and fee-for-service CDMO engagements. Orthogonal analytical services serve clients from early R&D through pharma innovators.
- [Sparge Chem Pvt. Ltd.](/companies/spargechem)
  - Pune-based provider of custom synthesis, medicinal chemistry, process development, and CRAMS/CDMO services for drug discovery and API intermediates. Offers FTE and fee-for-service engagement models with a 24-hour feasibility response.
- [Syngene International](/companies/syngeneintl)
  - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
- [TRiCBIO](/companies/tricbio)
  - TRiCBIO provides human organoid research services for efficacy, safety, mechanism and immune-context studies using PDO 2.0 and ALI platforms, supporting biopharma and CRO teams in candidate evaluation and translational research.
- [WuXi AppTec](/companies/wuxiapptec)
  - Global CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.